Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Short term Debt (2016 - 2025)

Historic Short term Debt for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $64.6 million.

  • Collegium Pharmaceutical's Short term Debt changed 0.0% to $64.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.6 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $64.6 million for FY2024, which is 6477.28% down from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Short term Debt of $64.6 million as of Q3 2025, which was down 0.0% from $64.6 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Short term Debt ranged from a high of $183.3 million in Q1 2023 and a low of $47.7 million during Q1 2021
  • Its 5-year average for Short term Debt is $112.6 million, with a median of $100.0 million in 2022.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Short term Debt skyrocketed by 23607.02% in 2022, and later plummeted by 6477.28% in 2024.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Short term Debt stood at $48.4 million in 2021, then soared by 236.07% to $162.5 million in 2022, then increased by 12.82% to $183.3 million in 2023, then crashed by 64.77% to $64.6 million in 2024, then changed by 0.0% to $64.6 million in 2025.
  • Its Short term Debt stands at $64.6 million for Q3 2025, versus $64.6 million for Q2 2025 and $64.6 million for Q1 2025.